Cochlear ltd (ASX:COH) | Cutting Edge Hearing Implants | Is It Worth Investing In ?

Cochlear ltd (ASX:COH) | Cutting Edge Hearing Implants | Is It Worth Investing In ?

From TechEyeSpy by PRSC Whitley

April 9, 2026 · 57 min · Season 3 · Episode 35

About this episode

This episode explores Cochlear Limited's position in the medical technology sector, focusing on its hearing implant solutions and investment potential.

Cochlear Limited (ASX: COH) is one of Australia’s most important medical technology companies, specialising in implantable hearing solutions rather than conventional hearing aids. In this episode, Tech-Eye-Spy explores the company through a full SWOT analysis, examining Cochlear’s global leadership in cochlear implants, its long installed-base economics, its innovation pipeline, and the practical risks that come with operating in a slow, highly regulated healthcare market. Cochlear says it has been the global leader in implantable hearing solutions for over 40 years, has helped more than 750,000 people hear with one or two implantable solutions, and sells into more than 180 countries. Start Your Own Agency — Practical Guides Security Firm Google Books https://play.google.com/store/books/details?id=TmTHEQAAQBAJ Amazon Kindle https://a.co/d/0aTWtIC2 Private Detective Agency Google Books https://play.google.com/store/books/details?id=tUbGEQAAQBAJ Amazon Kindle https://a.co/d/008weLsd Enforcement Agency Google Books https://play.google.com/store/books/details?id=S7fAEQAAQBAJ Amazon Kindle https://a.co/d/0hGgc2Dy

People in this episode

Host: PRSC Whitley

Topics covered

  • medical technology
  • hearing implants
  • investment analysis
  • SWOT analysis
  • healthcare market

Keywords

  • Cochlear Limited
  • hearing implants
  • ASX: COH
  • SWOT analysis
  • medical technology

Mentioned in this episode

Organizations: Cochlear Limited, ASX

Places: Australia, 180 countries

More episodes of TechEyeSpy

Explore listener stats, chart rankings, contacts and more on the TechEyeSpy podcast page.